Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2019 1
2020 1
2021 1
2022 7
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cheng long can (7 results)?
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis.
Liu H, Han CL, Tian BW, Ding ZN, Yang YF, Ma YL, Yang CC, Meng GX, Xue JS, Wang DX, Dong ZR, Chen ZQ, Hong JG, Li T. Liu H, et al. Among authors: han cl. Expert Rev Gastroenterol Hepatol. 2023 Jan-Jun;17(6):623-633. doi: 10.1080/17474124.2023.2212161. Epub 2023 May 9. Expert Rev Gastroenterol Hepatol. 2023. PMID: 37148261 Review.
Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma.
Tian BW, Han CL, Dong ZR, Tan SY, Wang DX, Li T. Tian BW, et al. Among authors: han cl. Cancers (Basel). 2022 Aug 21;14(16):4036. doi: 10.3390/cancers14164036. Cancers (Basel). 2022. PMID: 36011030 Free PMC article. Review.
A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response.
Ma YL, Yang YF, Wang HC, Yang CC, Yan LJ, Ding ZN, Tian BW, Liu H, Xue JS, Han CL, Tan SY, Hong JG, Yan YC, Mao XC, Wang DX, Li T. Ma YL, et al. Among authors: han cl. Front Pharmacol. 2023 Feb 24;14:1101749. doi: 10.3389/fphar.2023.1101749. eCollection 2023. Front Pharmacol. 2023. PMID: 36909185 Free PMC article.
Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients.
Han CL, Tian BW, Yan LJ, Ding ZN, Liu H, Mao XC, Tian JC, Xue JS, Tan SY, Dong ZR, Yan YC, Hong JG, Chen ZQ, Wang DX, Li T. Han CL, et al. Cancer Immunol Immunother. 2023 Jul;72(7):1957-1969. doi: 10.1007/s00262-023-03390-x. Epub 2023 Feb 22. Cancer Immunol Immunother. 2023. PMID: 36811662 Free PMC article. Review.
Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis.
Tian BW, Yan LJ, Ding ZN, Liu H, Han CL, Meng GX, Xue JS, Dong ZR, Yan YC, Hong JG, Chen ZQ, Wang DX, Li T. Tian BW, et al. Among authors: han cl. Int Immunopharmacol. 2023 Jan;114:109519. doi: 10.1016/j.intimp.2022.109519. Epub 2022 Nov 30. Int Immunopharmacol. 2023. PMID: 36459922 Review.
20 results